Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Cholesterol | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Cholesterol | hsa00330 | Arginine and proline metabolism | 4.86E-02 | 1 | P17707 | AMD1 | More | | Cholesterol | hsa00340 | Histidine metabolism | 4.52E-02 | 1 | O95954 | FTCD | More | | Cholesterol | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | | Cholesterol | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | | Cholesterol | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Cholesterol | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 6.96E-04 | 1 | Q9NY97 | B3GNT2 | More | | Cholesterol | hsa00561 | Glycerolipid metabolism | 2.51E-02 | 2 | P51648, P23743 | ALDH3A2, DGKA | More | | Cholesterol | hsa00562 | Inositol phosphate metabolism | 7.30E-04 | 4 | P27987, Q96PE3, P19174, P42338 | ITPKB, INPP4A, PLCG1, PIK3CB | More | | Cholesterol | hsa00564 | Glycerophospholipid metabolism | 9.70E-03 | 2 | Q9Y259, P49619 | CHKB, DGKG | More | | Cholesterol | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 3.78E-02 | 1 | Q9NY97 | B3GNT2 | More | | Cholesterol | hsa00620 | Pyruvate metabolism | 2.51E-02 | 2 | P40925, P51648 | MDH1, ALDH3A2 | More | | Cholesterol | hsa00630 | Glyoxylate and dicarboxylate metabolism | 3.80E-05 | 2 | P40925, P15104 | MDH1, GLUL | More | | Cholesterol | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Cholesterol | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Cholesterol | hsa00982 | Drug metabolism - cytochrome P450 | 1.06E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Cholesterol | hsa00983 | Drug metabolism - other enzymes | 8.59E-04 | 4 | P32320, P05164, Q16772, P09211 | CDA, MPO, GSTA3, GSTP1 | More | | Cholesterol | hsa01100 | Metabolic pathways | 1.17E-04 | 30 | P35790, Q9Y259, Q16772, P09211, Q9UJ14, P30041, P15104, P51648, P42338, Q96PE3, P19174, P27987, Q13370, Q13956, P40925, P40926, Q7KZN9, P15121, P23743, P49619, O95954, Q02318, Q9UHK6, P43034, Q86VZ5, P09917, Q9UBX8, Q53FZ2, P35573, Q9BQB6 | CHKA, CHKB, GSTA3, GSTP1, GGTL3, PRDX6, GLUL, ALDH3A2, PIK3CB, INPP4A, PLCG1, ITPKB, PDE3B, PDE6H, MDH1, MDH2, COX15, AKR1B1, DGKA, DGKG, FTCD, CYP27A1, AMACR, PAFAH1B1, SGMS1, ALOX5, B4GALT6, ACSM3, AGL, VKORC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P35790 | CHKA | Choline kinase alpha | -0.717 | P11388 | TOP2A | DNA topoisomerase 2-alpha | Q9Y259 | CHKB | Choline/ethanolamine kinase | -0.751 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.793 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P09211 | GSTP1 | Glutathione S-transferase P | 0.712 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | 0.748 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P30041 | PRDX6 | Peroxiredoxin-6 | 0.75 | P06746 | POLB | DNA polymerase beta | P15104 | GLUL | Glutamine synthetase | -0.71 | P06746 | POLB | DNA polymerase beta | P51648 | ALDH3A2 | Aldehyde dehydrogenase family 3 member A2 | 0.845 | P06746 | POLB | DNA polymerase beta | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.74 | P06746 | POLB | DNA polymerase beta | Q96PE3 | INPP4A | Inositol polyphosphate-4-phosphatase type I A | 0.711 | P06746 | POLB | DNA polymerase beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.787 | P06746 | POLB | DNA polymerase beta | P27987 | ITPKB | Inositol-trisphosphate 3-kinase B | 0.835 | P06746 | POLB | DNA polymerase beta | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | -0.758 | P11388 | TOP2A | DNA topoisomerase 2-alpha | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0.703 | P06746 | POLB | DNA polymerase beta | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | 0.837 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | 0.81 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q7KZN9 | COX15 | Cytochrome c oxidase assembly protein COX15 homolog | 0.764 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | 1 | P06746 | POLB | DNA polymerase beta | P23743 | DGKA | Diacylglycerol kinase alpha | 0.814 | P11388 | TOP2A | DNA topoisomerase 2-alpha | P49619 | DGKG | Diacylglycerol kinase gamma | 0.926 | P11388 | TOP2A | DNA topoisomerase 2-alpha | O95954 | FTCD | Formimidoyltransferase-cyclodeaminase | -0.718 | P11388 | TOP2A | DNA topoisomerase 2-alpha | Q02318 | CYP27A1 | Sterol 26-hydroxylase, mitochondrial | -0.879 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.704 | P06746 | POLB | DNA polymerase beta | P43034 | PAFAH1B1 | Platelet-activating factor acetylhydrolase IB subunit beta | 0.726 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.736 | P06746 | POLB | DNA polymerase beta | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | -0.789 | P11388 | TOP2A | DNA topoisomerase 2-alpha | Q9UBX8 | B4GALT6 | Beta-1,4-galactosyltransferase 6 | 0.869 | P06746 | POLB | DNA polymerase beta | Q53FZ2 | ACSM3 | Acyl-coenzyme A synthetase ACSM3, mitochondrial | -0.744 | P11388 | TOP2A | DNA topoisomerase 2-alpha | P35573 | AGL | Glycogen debranching enzyme | 0.759 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9BQB6 | VKORC1 | Vitamin K epoxide reductase complex subunit 1 | 0.731 |
| Cholesterol | hsa01210 | 2-Oxocarboxylic acid metabolism | 1.91E-02 | 1 | P50213 | IDH3A | More | | Cholesterol | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 7.30E-04 | 4 | Q92529, P19174, P42338, Q9NRA1 | SHC3, PLCG1, PIK3CB, PDGFC | More | | Cholesterol | hsa01524 | Platinum drug resistance | 3.80E-03 | 4 | O15392, Q16772, P09211, P11388 | BIRC5, GSTA3, GSTP1, TOP2A | More | | Cholesterol | hsa03013 | RNA transport | 8.19E-04 | 7 | Q15287, Q9UBU9, P35658, P63279, P55884, O15371, P20042 | RNPS1, NXF1, NUP214, UBE2I, EIF3B, EIF3D, EIF2S2 | More | | Cholesterol | hsa03018 | RNA degradation | 5.00E-02 | 1 | Q9NQT4 | EXOSC5 | More | | Cholesterol | hsa03040 | Spliceosome | 3.98E-02 | 4 | Q15427, P38159, P61978, P11142 | SF3B4, RBMX, HNRPK, HSPA8 | More | | Cholesterol | hsa03060 | Protein export | 1.43E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Cholesterol | hsa03320 | PPAR signaling pathway | 1.62E-02 | 2 | Q13133, Q02318 | NR1H3, CYP27A1 | More | | Cholesterol | hsa04012 | ErbB signaling pathway | 8.47E-05 | 8 | P21860, P16333, Q92529, Q13557, P19174, O14944, P42338, P01106 | ERBB3, NCK1, SHC3, CAMK2D, PLCG1, EREG, PIK3CB, MYC | More | | Cholesterol | hsa04014 | Ras signaling pathway | 2.29E-04 | 7 | P42338, Q92529, Q9NRA1, P49767, P63218, P50151, P19174 | PIK3CB, SHC3, PDGFC, VEGFC, GNG5, GNG10, PLCG1 | More | | Cholesterol | hsa04015 | Rap1 signaling pathway | 3.91E-02 | 4 | Q9NRA1, P49767, P42338, P19174 | PDGFC, VEGFC, PIK3CB, PLCG1 | More | | Cholesterol | hsa04020 | Calcium signaling pathway | 7.29E-06 | 11 | P27987, Q96DU7, P45880, Q13557, P21860, P19174, P0DP24, P51828, P23634, Q9NRA1, P49767 | ITPKB, ITPKC, VDAC2, CAMK2D, ERBB3, PLCG1, CALM2, ADCY7, ATP2B4, PDGFC, VEGFC | More | | Cholesterol | hsa04022 | cGMP-PKG signaling pathway | 4.72E-02 | 4 | Q99941, P23634, P51828, P45880 | CREBL1, ATP2B4, ADCY7, VDAC2 | More | | Cholesterol | hsa04024 | cAMP signaling pathway | 3.79E-02 | 3 | P51828, P0DP24, P23634 | ADCY7, CALM2, ATP2B4 | More | | Cholesterol | hsa04062 | Chemokine signaling pathway | 2.08E-04 | 10 | P25024, P25025, P07948, P42338, P19174, Q92529, P63218, P50151, P49407, P49841 | CXCR1, CXCR2, LYN, PIK3CB, PLCG1, SHC3, GNG5, GNG10, ARRB1, GSK3B | More | | Cholesterol | hsa04070 | Phosphatidylinositol signaling system | 3.19E-04 | 5 | P19174, P42338, P23743, Q96PE3, P27987 | PLCG1, PIK3CB, DGKA, INPP4A, ITPKB | More | | Cholesterol | hsa04071 | Sphingolipid signaling pathway | 9.99E-04 | 5 | Q9H228, P01375, Q13510, Q13362, Q9UQC2 | EDG8, TNF, ASAH1, PPP2R5C, GAB2 | More | | Cholesterol | hsa04072 | Phospholipase D signaling pathway | 1.85E-04 | 6 | P42338, Q92529, P19174, Q14344, P23743, Q9NRA1 | PIK3CB, SHC3, PLCG1, GNA13, DGKA, PDGFC | More | | Cholesterol | hsa04110 | Cell cycle | 1.79E-03 | 8 | Q9UBD5, P06493, O75293, P30304, P33981, P42773, P01106, Q13547 | ORC3, CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC, HDAC1 | More | | Cholesterol | hsa04114 | Oocyte meiosis | 3.15E-04 | 8 | P51812, Q02750, P0DP24, P16298, Q17RY0, P51828, P27348, Q13362 | RPS6KA3, MAP2K1, CALM2, PPP3CB, CPEB4, ADCY7, YWHAQ, PPP2R5C | More | | Cholesterol | hsa04141 | Protein processing in endoplasmic reticulum | 3.64E-02 | 5 | Q99941, O75460, P11142, Q9H3Z4, P07900 | CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1 | More | | Cholesterol | hsa04144 | Endocytosis | 4.10E-02 | 3 | O75351, P62491, Q14161 | VPS4B, RAB11A, GIT2 | More | | Cholesterol | hsa04150 | mTOR signaling pathway | 2.28E-03 | 6 | P42338, Q02750, Q9NQL2, P51812, Q13322, P49841 | PIK3CB, MAP2K1, RRAGD, RPS6KA3, GRB10, GSK3B | More | | Cholesterol | hsa04151 | PI3K-Akt signaling pathway | 2.55E-03 | 8 | P42338, Q9NRA1, P49767, P08238, P63218, P50151, O15335, P14784 | PIK3CB, PDGFC, VEGFC, HSP90AB1, GNG5, GNG10, CHAD, IL2RB | More | | Cholesterol | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Cholesterol | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Cholesterol | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.31E-03 | 6 | P51828, Q99941, Q13362, P0DP24, Q13557, P23634 | ADCY7, CREBL1, PPP2R5C, CALM2, CAMK2D, ATP2B4 | More | | Cholesterol | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Cholesterol | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Cholesterol | hsa04370 | VEGF signaling pathway | 8.20E-05 | 5 | P19174, P16298, P42338, Q05397, Q02750 | PLCG1, PPP3CB, PIK3CB, PTK2, MAP2K1 | More | | Cholesterol | hsa04371 | Apelin signaling pathway | 1.24E-02 | 4 | P63218, P50151, Q13370, Q14344 | GNG5, GNG10, PDE3B, GNA13 | More | | Cholesterol | hsa04390 | Hippo signaling pathway | 2.17E-03 | 5 | P63261, P84022, Q13485, O15105, Q13489 | ACTG1, SMAD3, SMAD4, SMAD7, BIRC3 | More | | Cholesterol | hsa04510 | Focal adhesion | 1.55E-02 | 5 | P42338, O15335, Q9NRA1, P49767, Q92529 | PIK3CB, CHAD, PDGFC, VEGFC, SHC3 | More | | Cholesterol | hsa04530 | Tight junction | 4.35E-02 | 2 | P63261, Q92974 | ACTG1, ARHGEF2 | More | | Cholesterol | hsa04610 | Complement and coagulation cascades | 3.16E-03 | 2 | P00734, P0C0L4 | F2, C4A | More | | Cholesterol | hsa04611 | Platelet activation | 4.11E-02 | 3 | P42338, Q14344, P07948 | PIK3CB, GNA13, LYN | More | | Cholesterol | hsa04650 | Natural killer cell mediated cytotoxicity | 2.94E-02 | 3 | P16298, P50591, Q02750 | PPP3CB, TNFSF10, MAP2K1 | More | | Cholesterol | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | | Cholesterol | hsa04658 | Th1 and Th2 cell differentiation | 1.59E-07 | 8 | P07766, P20963, P19174, P01730, P06239, P42224, P14784, Q13761 | CD3E, CD247, PLCG1, CD4, LCK, STAT1, IL2RB, RUNX3 | More | | Cholesterol | hsa04659 | Th17 cell differentiation | 2.31E-06 | 12 | P25963, P19174, P01730, P06239, P42224, P14784, P14778, P84022, Q13485, P08238, P07766, P20963 | NFKBIA, PLCG1, CD4, LCK, STAT1, IL2RB, IL1R1, SMAD3, SMAD4, HSP90AB1, CD3E, CD247 | More | | Cholesterol | hsa04660 | T cell receptor signaling pathway | 3.69E-03 | 8 | P42338, P19174, P16333, P07766, P20963, P01730, P06239, P49841 | PIK3CB, PLCG1, NCK1, CD3E, CD247, CD4, LCK, GSK3B | More | | Cholesterol | hsa04662 | B cell receptor signaling pathway | 9.27E-05 | 6 | P49841, P42338, P60033, P07948, P21854, Q8N149 | GSK3B, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Cholesterol | hsa04664 | Fc epsilon RI signaling pathway | 7.30E-04 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Cholesterol | hsa04666 | Fc gamma R-mediated phagocytosis | 1.73E-02 | 3 | P07948, P42338, P19174 | LYN, PIK3CB, PLCG1 | More | | Cholesterol | hsa04668 | TNF signaling pathway | 4.74E-02 | 3 | Q99941, P01584, O95429 | CREBL1, IL1B, BAG4 | More | | Cholesterol | hsa04720 | Long-term potentiation | 1.38E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Cholesterol | hsa04722 | Neurotrophin signaling pathway | 4.87E-02 | 3 | P42338, P19174, Q92529 | PIK3CB, PLCG1, SHC3 | More | | Cholesterol | hsa04724 | Glutamatergic synapse | 1.05E-03 | 4 | P43003, P63218, P50151, P15104 | SLC1A3, GNG5, GNG10, GLUL | More | | Cholesterol | hsa04725 | Cholinergic synapse | 1.73E-02 | 3 | P63218, P50151, P42338 | GNG5, GNG10, PIK3CB | More | | Cholesterol | hsa04726 | Serotonergic synapse | 3.41E-02 | 3 | P63218, P50151, P09917 | GNG5, GNG10, ALOX5 | More | | Cholesterol | hsa04727 | GABAergic synapse | 9.19E-04 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Cholesterol | hsa04730 | Long-term depression | 1.56E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Cholesterol | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.74E-02 | 3 | P01584, P51828, Q13557 | IL1B, ADCY7, CAMK2D | More | | Cholesterol | hsa04910 | Insulin signaling pathway | 2.44E-03 | 6 | P22694, P06737, Q92529, Q13370, P42338, P49841 | PRKACB, PYGL, SHC3, PDE3B, PIK3CB, GSK3B | More | | Cholesterol | hsa04911 | Insulin secretion | 1.48E-02 | 3 | P51828, Q99941, Q13557 | ADCY7, CREBL1, CAMK2D | More | | Cholesterol | hsa04914 | Progesterone-mediated oocyte maturation | 1.58E-03 | 6 | Q17RY0, P42338, Q13370, P08238, P51812, Q02750 | CPEB4, PIK3CB, PDE3B, HSP90AB1, RPS6KA3, MAP2K1 | More | | Cholesterol | hsa04915 | Estrogen signaling pathway | 7.27E-04 | 7 | Q99941, P51828, P42338, Q92529, P07900, P08238, P11142 | CREBL1, ADCY7, PIK3CB, SHC3, HSP90AA1, HSP90AB1, HSPA8 | More | | Cholesterol | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Cholesterol | hsa04923 | Regulation of lipolysis in adipocytes | 3.64E-02 | 2 | Q13370, P42338 | PDE3B, PIK3CB | More | | Cholesterol | hsa04925 | Aldosterone synthesis and secretion | 1.75E-04 | 5 | Q99941, P51828, P0DP24, Q13557, P23634 | CREBL1, ADCY7, CALM2, CAMK2D, ATP2B4 | More | | Cholesterol | hsa04926 | Relaxin signaling pathway | 1.31E-03 | 5 | P42338, P63218, P50151, P49767, Q92529 | PIK3CB, GNG5, GNG10, VEGFC, SHC3 | More | | Cholesterol | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Cholesterol | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.47E-03 | 6 | P84022, Q13485, P10415, P42338, P49767, P19174 | SMAD3, SMAD4, BCL2, PIK3CB, VEGFC, PLCG1 | More | | Cholesterol | hsa04934 | Cushing syndrome | 3.48E-03 | 4 | Q99941, P51828, O15169, Q13557 | CREBL1, ADCY7, AXIN1, CAMK2D | More | | Cholesterol | hsa04935 | Growth hormone synthesis, secretion and action | 2.78E-02 | 3 | P19174, P42338, Q92529 | PLCG1, PIK3CB, SHC3 | More | | Cholesterol | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 2.09E-02 | 2 | P23634, P62491 | ATP2B4, RAB11A | More | | Cholesterol | hsa04962 | Vasopressin-regulated water reabsorption | 1.80E-02 | 2 | P62491, P46459 | RAB11A, NSF | More | | Cholesterol | hsa04970 | Salivary secretion | 3.20E-03 | 3 | P51828, P23634, P0DP24 | ADCY7, ATP2B4, CALM2 | More | | Cholesterol | hsa04971 | Gastric acid secretion | 1.48E-02 | 3 | P51828, P15311, Q13557 | ADCY7, VIL2, CAMK2D | More | | Cholesterol | hsa04972 | Pancreatic secretion | 4.94E-03 | 3 | P23634, P51828, P62491 | ATP2B4, ADCY7, RAB11A | More | | Cholesterol | hsa04973 | Carbohydrate digestion and absorption | 1.10E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Cholesterol | hsa04975 | Fat digestion and absorption | 3.43E-02 | 1 | O14494 | PLPP1 | More | | Cholesterol | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Cholesterol | hsa05010 | Alzheimer disease | 2.07E-02 | 7 | Q92542, P05496, P12074, O75460, P01584, O15169, P45880 | NCSTN, ATP5G1, COX6A1, ERN1, IL1B, AXIN1, VDAC2 | More | | Cholesterol | hsa05020 | Prion disease | 1.81E-02 | 7 | P01584, P46531, P11142, P05496, P12074, P45880, Q99941 | IL1B, NOTCH1, HSPA8, ATP5G1, COX6A1, VDAC2, CREBL1 | More | | Cholesterol | hsa05032 | Morphine addiction | 2.22E-02 | 3 | P63218, P50151, Q13370 | GNG5, GNG10, PDE3B | More | | Cholesterol | hsa05100 | Bacterial invasion of epithelial cells | 3.64E-02 | 2 | P42338, Q92529 | PIK3CB, SHC3 | More | | Cholesterol | hsa05132 | Salmonella infection | 2.04E-02 | 4 | P25963, Q13489, P10415, Q9BQS8 | NFKBIA, BIRC3, BCL2, FYCO1 | More | | Cholesterol | hsa05133 | Pertussis | 2.24E-02 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Cholesterol | hsa05143 | African trypanosomiasis | 4.81E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Cholesterol | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | | Cholesterol | hsa05146 | Amoebiasis | 2.58E-02 | 5 | P14778, P27930, P42338, P11215, P12814 | IL1R1, IL1R2, PIK3CB, ITGAM, ACTN1 | More | | Cholesterol | hsa05161 | Hepatitis B | 8.49E-03 | 4 | P25963, Q13485, P10415, P84022 | NFKBIA, SMAD4, BCL2, SMAD3 | More | | Cholesterol | hsa05162 | Measles | 3.91E-02 | 4 | P14784, P07766, P42338, P11142 | IL2RB, CD3E, PIK3CB, HSPA8 | More | | Cholesterol | hsa05163 | Human cytomegalovirus infection | 1.14E-02 | 5 | P42338, P63218, P50151, Q14344, P30101 | PIK3CB, GNG5, GNG10, GNA13, PDIA3 | More | | Cholesterol | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 6.22E-04 | 9 | P42338, P62879, P63218, P50151, P19174, P16298, Q02750, P07948, P0CG47 | PIK3CB, GNB2, GNG5, GNG10, PLCG1, PPP3CB, MAP2K1, LYN, UBB | More | | Cholesterol | hsa05169 | Epstein-Barr virus infection | 3.34E-02 | 5 | P42338, P07948, P30101, Q13761, P07766 | PIK3CB, LYN, PDIA3, RUNX3, CD3E | More | | Cholesterol | hsa05170 | Human immunodeficiency virus 1 infection | 1.36E-04 | 11 | P42338, Q02750, P62879, P63218, P50151, P16298, Q05397, P30101, P19174, P07766, P20333 | PIK3CB, MAP2K1, GNB2, GNG5, GNG10, PPP3CB, PTK2, PDIA3, PLCG1, CD3E, TNFRSF1B | More | | Cholesterol | hsa05200 | Pathways in cancer | 3.05E-02 | 8 | P42338, P08238, P19174, P49767, P63218, P50151, Q14344, P14784 | PIK3CB, HSP90AB1, PLCG1, VEGFC, GNG5, GNG10, GNA13, IL2RB | More | | Cholesterol | hsa05203 | Viral carcinogenesis | 4.62E-02 | 3 | Q12933, P42229, Q15283 | TRAF2, STAT5A, RASA2 | More | | Cholesterol | hsa05204 | Chemical carcinogenesis | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Cholesterol | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | | Cholesterol | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Cholesterol | hsa05212 | Pancreatic cancer | 3.52E-02 | 2 | P84022, Q13485 | SMAD3, SMAD4 | More | | Cholesterol | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | | Cholesterol | hsa05214 | Glioma | 9.49E-03 | 3 | Q92529, P42338, P19174 | SHC3, PIK3CB, PLCG1 | More | | Cholesterol | hsa05215 | Prostate cancer | 4.87E-02 | 3 | Q9NRA1, P08238, P42338 | PDGFC, HSP90AB1, PIK3CB | More | | Cholesterol | hsa05218 | Melanoma | 3.64E-02 | 2 | Q9NRA1, P42338 | PDGFC, PIK3CB | More | | Cholesterol | hsa05220 | Chronic myeloid leukemia | 1.25E-02 | 3 | Q13485, P25963, P84022 | SMAD4, NFKBIA, SMAD3 | More | | Cholesterol | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | | Cholesterol | hsa05223 | Non-small cell lung cancer | 4.24E-02 | 3 | P19174, Q9HC35, O75293 | PLCG1, EML4, GADD45B | More | | Cholesterol | hsa05226 | Gastric cancer | 4.33E-03 | 5 | Q02750, O15169, P84022, Q13485, P10415 | MAP2K1, AXIN1, SMAD3, SMAD4, BCL2 | More | | Cholesterol | hsa05231 | Choline metabolism in cancer | 1.36E-05 | 6 | P42338, Q9NRA1, Q9Y259, P19174, P23743, P49619 | PIK3CB, PDGFC, CHKB, PLCG1, DGKA, DGKG | More | | Cholesterol | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.50E-04 | 8 | P42338, P19174, P07766, P20963, P06239, P42224, Q9HC35, P01730 | PIK3CB, PLCG1, CD3E, CD247, LCK, STAT1, EML4, CD4 | More | | Cholesterol | hsa05340 | Primary immunodeficiency | 4.24E-02 | 3 | P01730, P07766, P06239 | CD4, CD3E, LCK | More | | |